In conclusion, all these results suggested that PIM1 could promote breast cancer cells to gain stem cell–like traits and inhibiting PIM1 promised to exert anti‐BrCSC effects with RUNX3 being indispensable in this process. This evidence concerns the gene RUNX3 and breast carcinoma.